Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Sitagliptin in Type 2 Diabetes (SAFEGUARD)
NCT01744236Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2013
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide, sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Amsterdam University Medical Center. Started Apr 2013; status: completed.
02
Drugs
liraglutidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01744236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01744236.